Molecular monitoring of chronic myeloid leukemia: present and future.

about

Panomics for Precision Medicine.Pharmacology and pharmacokinetics of imatinib in pediatric patients.Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

P2860

Q47348974-9BC443D8-4D5E-4B03-ADBD-D1C3E25E2652 Q50094239-7A4ECEA0-D270-49C9-AFC0-AC7716978524 Q57821741-CB12C82E-C5DD-49CC-8F49-66FA0C3B43F3

P2860

Molecular monitoring of chronic myeloid leukemia: present and future.

Item

http://www.wikidata.org/entity/Q38828713

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Molecular monitoring of chronic myeloid leukemia: present and future.

@en

type

Item

label

Molecular monitoring of chronic myeloid leukemia: present and future.

@en

prefLabel

Molecular monitoring of chronic myeloid leukemia: present and future.

@en

P1476

Molecular monitoring of chronic myeloid leukemia: present and future.

@en

P2093

Cecilia Ching Sze Yeung

http://www.w3.org/2001/XMLSchema#string

Daniel Egan

http://www.w3.org/2001/XMLSchema#string

Jerald P Radich

http://www.w3.org/2001/XMLSchema#string

P2860

Selective aluminum passivation for targeted immobilization of single DNA polymerase molecules in zero-mode waveguide nanostructures.

Real-time DNA sequencing from single polymerase molecules

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Identification and correction of systematic error in high-throughput sequence data

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Performance comparison of benchtop high-throughput sequencing platforms.

Detection of ultra-rare mutations by next-generation sequencing.

P304

1083-1091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737159.2016.1227243

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27552202

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5161535

http://www.w3.org/2001/XMLSchema#string

Molecular monitoring of chronic myeloid leukemia: present and future.

about

P2860

P2860

Molecular monitoring of chronic myeloid leukemia: present and future.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932